In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility.
Rheumatol Int. 1998;18(3):103-6. doi: 10.1007/s002960050066.
Rheumatol Int. 1998.
PMID: 9833250
Clinical Trial.